• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses

tetano

Editor, Senior Moderator
J Virol. 2015 Jun 10. pii: JVI.01295-15. [Epub ahead of print]
[h=1]Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses.[/h] Wang J[SUP]1[/SUP], Chen Z[SUP]1[/SUP], Bao L[SUP]2[/SUP], Zhang W[SUP]1[/SUP], Xue Y[SUP]1[/SUP], Pang X[SUP]3[/SUP], Zhang X[SUP]4[/SUP], Qin C[SUP]5[/SUP], Jin Q[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] H7N9 caused a significant global health concern, due to its severe infection and approximately 35% mortality in humans. By screening a Fab antibody phage library derived from patients who recovered from H7N9 infections, we characterized two human monoclonal antibodies (HuMAbs), HNIgGD5 and HNIgGH8. The epitope of these two antibodies was dependent on two residues in the receptor binding site at positions V186 and L226 of the hemagglutinin glycoprotein. Both antibodies possessed high neutralizing activity.
Copyright ? 2015, American Society for Microbiology. All Rights Reserved.


PMID: 26063436 [PubMed - as supplied by publisher]
 
Back
Top Bottom